MALDI biotyping-like method to address bee health 1 7 1 8
Abstract: 1 9
Among pollinator insects, bees undoubtedly account for the most important species. They play a 2 0 critical role in boosting reproduction of wild and commercial plants and therefore contribute to the 2 1 maintenance of plant biodiversity and sustainability of food webs. In the last few decades, 2 2 domesticated and wild bees have been subjected to biotic and abiotic threats, alone or in combination, 2 3
causing various health disorders. Therefore, monitoring solutions to improve bee health are 2 4 increasingly necessary. MALDI mass spectrometry has emerged within this decade as a powerful 2 5
technology to biotype micro-organisms. This method is currently and routinely used in clinical 2 6 diagnosis where molecular mass fingerprints corresponding to major protein signatures are matched 2 7 against databases for real-time identification. Based on this strategy, we developed MALDI 2 8
BeeTyping as a proof of concept to monitor significant hemolymph molecular changes in honey bees 2 9
upon infection with a series of entomopathogenic Gram-positive and -negative bacteria. A Serratia 3 0 marcescens strain isolated from one "naturally" infected honey bee collected from the field was also 3 1 considered. We performed a series of individually recorded hemolymph molecular mass fingerprints 3 2
and built, to our knowledge, the first computational model made of nine molecular signatures with a 3 3 predictive score of 97.92%. Hence, we challenged our model by classifying a training set of individual 3 4
bees' hemolymph and obtained overall recognition of 91.93%. Through this work, we aimed at 3 5
introducing a novel, realistic, and time-saving high-throughput biotyping-like strategy that addresses 3 6 honey bee health in infectious conditions and on an individual scale through direct "blood tests". 3 7 3 8 Keywords: 3 9
MALDI biotyping, Bee health, Immunity, Apis mellifera, Molecular mass fingerprint, Infection, 4 0
Serratia marcescens, Computational model, Antimicrobial peptides 4 1 4 2
Significance Statement: 4 3
Domesticated and wild bees worldwide represent the most active and valuable pollinators that ensure 4 4 plant biodiversity and the success of many crops. These pollinators and others are exposed to 4 5 deleterious pathogens and environmental stressors. Despite efforts to better understand how these 4 6
threats affect honey bee health status, solutions are still crucially needed to help beekeepers, scientists 4 7
and stakeholders in obtaining either a prognosis, an early diagnosis or a diagnosis of the health status 4 8 of the apiaries. In this study, we describe a new method to investigate honey bee health by a simple 4
Results & Discussion 1 1 4 MALDI-TOF MS Biotyping successfully diagnosed a bacterial strain isolated from 1 1 5 honey bee hemolymph. 1 1 6
In order to generate relevant biological models of honey bee infections, we used the bacteria 1 1 7
Micrococcus luteus, Pectobacterium carotovorum subsp. carotovorum and Serratia entomophila. M. 1 1 8
luteus is a Gram-positive bacterial strain frequently used when monitoring insect immunity (43) and 1 1 9
has been shown to colonize bee hives and gastrointestinal tracts of honey bees (44) while P. 1 2 0 carotovorum subsp. carotovorum (45) and S. entomophila (Institut Pasteur, CIP102919) are two 1 2 1 bacterial strains that trigger a systemic immune response in insects. We also performed an additional 1 2 2 model of infection using a Serratia marcescens strain (SmBIOP160412, Lab. collection) isolated from 1 2 3 a naturally infected honey bee collected in the field. To certify the constructed biological models of 1 2 4
infection, the four bacterial strains were classified by MALDI MS biotyping ( Figure 1 ). As shown, the 1 2 5
individual MFPs of the different strains detailed below and represented by the spectral gel views 1 2 6
passed the threshold score of identification with a significant score (reliability score ≥ 2) and 1 2 7
successfully matched the Bruker reference strains (see Fig. 1 Moreover, applied to the bacterial strain SmBIOP160412 isolated and cultured from an isolate 1 3 0 obtained from a naturally infected honey bee, MALDI MS biotyping demonstrated for the first time to 1 3 1 our knowledge, its ability to characterize a field bacterial infection in Apis mellifera. This identified 1 3 2 bacterial strain, namely S. marcescens, is known to be a widespread pathogen of adult honey bees 1 3 3 (46), and a virulent opportunist, taking advantage of disturbed microbiota to develop in honey bee guts 1 3 4
after exposure to the pesticide glyphosate (47). 1 3 5 1  3  6 -negative biological models of infection directly from honey bee hemolymph 1 3 7
MALDI-TOF MS BeeTyping as a new approach to discriminate Gram-positive and
A set of 64 MALDI MS spectra was recorded from individual hemolymph samples. These spectra 1 3 8
were obtained from 22 control honey bees and from 23 and 19 honey bees individually infected with 1 3 9
the Gram-positive M. luteus or the Gram-negative P. carotovorum subsp. carotovorum, respectively. 1 4 0
An averaged spectrum, containing 110 MALDI MS ion peaks (MFP , Table S1 ), was built for each of 1 4 1 the three biological models (Figure 2A ). Statistical analysis based on Principal Component Analysis 1 4 2 (PCA) and performed on these MFPs clearly segregated the three biological models ( Figure 2B ). As 1 4 3
shown by the PCA plot score, the individual spectra were clustered in accordance with their 1 4 4 corresponding models and were segregated based on their mass fingerprints. The unsupervised 1 4 5
hierarchical clustering of hemolymph samples, classified almost all of the individual MFPs with 1 4 6 respect to their corresponding biological models ( Figure 2C ). Out of 64 normalized spectra used to 1 4 7 build the clustering dendrogram, four and three recorded mismatched spectra were observed, 1 4 8 Abaecin, Defensin, Hymenoptaecin and Apidaecin did not differ between infected and 3 0 2 non-experimentally infected control honey bees. These results support the idea that 3 0 3 markers other than AMPs need to be identified and monitored to efficiently 3 0 4 discriminate bacterial infections in honey bee hemolymph. As we demonstrated, the 3 0 5
correlation of the molecular fingerprints and the AMPs in hemolymph allo wed us to 3 0 6 discriminate the three different models. In order to determine ho w specific were the 3 0 7
nine markers of the classifier to the control, M. luteus and P. carotovorum subsp. 3 0 8
carotovorum biological models, we tested the classification of the hemolymph mass fingerprints of 3 0 9
honey bees infected using the two Serratia strains. We submitted 13 MALDI mass fingerprints of 3 1 0
hemolymph from infected bees with S. entomophila to the classifier. One was classified as control Nevertheless, some spectra matched against the control and the M. luteus models. Taking  3  2  1 altogether, these results suggest that the BeeTyping approach generates specific 3 2 2 molecular barcodes defined accordingly to biological models. Along with most relevant, technically feasible and primary observation-based health status responses to stressors through the matured effector molecules circulating in the hemolymph. These effectors include the products of selected immune genes (i.e. genes coding for 3 3 1 Apidaecin, Defensin, Hymenoptaecin, and Abaecin) and other molecular mass fingerprints of 3 3 2 stress that we are under characterization through a proteomic approach. Our approach of individual level, the honeybee health parameters including its immunity stage with regards to 3 3 7 bacterial stressors. Moreover, as a robust and sensitive molecular approach, MALDI BeeTyping has 3 3 8
several advantages over other molecular biology techniques and visual observations, such as (i) the 3 3 9
use of a drop of hemolymph allowing to keep the rest of the body for complementary molecular 3 4 0 measurements such as PCR, (ii) a very simple and fast sample preparation, (iii) a short processing time 3 4 1 (data acquisition and processing), (iv) low consumable costs, and (v) a user friendly workflow that can 3 4 2 be standardized and automated for cost-effective high throughput use. We believe that future The BeeTyping strategy relies on a workflo w divided into four major steps summarized 3 5 3
in Table S2 and described in this section. 3 5 4
Biological models 3 5 5
Bacterial strains 3 5 6
To generate biological models of infection, we used the Gram-negative strains 3 5 7
Pectobacterium carotovorum subsp. carotovorum 15 (formerly Erwinia carotovora 3 5 8 carotovora 15 CFBP2141, generous gift from Bruno Lemaitre, EPFL Switzerland), 3 5 9
Serratia entomophila (Institut Pasteur, CIP102919) and a Serratia marcescens strain 3 6 0 (SmBIOP160412, our laboratory collection) isolated within the haemocoel from a 3 6 1 naturally infected Apis mellifera honey bee collected in the field, and the Gram-positive 3 6 2
Micrococcus luteus (ATCC 4698). Bacteria were cultured in Luria Bertani (LB) medium 3 6 3 overnight at 32°C. 3 6 4
Bacterial strain identification by MALDI biotyping 3 6 5
The Pectobacterium carotovorum subsp. carotovorum, Serratia marcescens, S. entomophila and 3 6 6
Micrococcus luteus strains were identified follo wing Bruker's recommendations. Briefly, 3 6 7 one isolated colony of bacteria was spread onto a MALDI plate dedicated for 3 6 8 microorganism identifications (MALDI Biotarget 48 polished steel) and mixed with 3 6 9
1µ L of Alpha-Cyano-4-hydroxycinnamic acid (4-HCCA) MALDI matrix. Spectra were 3 7 0 recorded using the MALDI-TOF MS AutoFlex III instrument and the associated materials, 3 7 1 chemicals and software package used for MALDI biotyping were all from Bruker Daltonik 3 7 2 (Germany) using the standard method (pre-processing step for which the lo wer mass 3 7 3
was set at 2,000, with a resolution of 5, and a compressing factor of 1). The smoothing 3 7 4 frame size was 20Da and the search windo w was 10Da with three runs for the baseline 3 7 5
subtraction. For the peak-picking, the maximum number of peaks was set at 200, with a 3 7 6 threshold of 0.0045. The method of peak-picking was based on peak fitting using the 3 7 7
Gauss profile. The recorded spectra were matched against the dedicated database MBT 3 7 8
Compass 4.1, build 70. The obtained gel spectra for the identified bacteria and their 3 7 9
corresponding dendrograms were built under MBT Compass Explorer 4.1 using the 3 8 0 standard method of identification. For external calibration of the mass spectrometer, a 3 8 1 mix of 1µ L of bacterial test standard proteins (BTS) covering the entire mass range 3 8 2 (m/z 2,000-20,000) of the acquisition method was analyzed using the same protocol. Experimental infections were performed on newly-emerged honey bee workers (less 3 8 5 than 12h old). To design the computational analyses, a training set of spectra was built 3 8 6 using non experimentally infected (unpicked control) bees and bees infected with either 3 8 7
Pectobacterium carotovorum subsp. carotovorum 15, M. luteus, S. entomophila or the 3 8 8
isolated Serratia marcescens SmBIOP160412 strain. Infections were performed by 3 8 9
pricking honey bees individually in the anterior lateral thorax (spiracle) using a fine 3 9 0 needle (Fine Science Tools, Germany) dipped into a freshly concentrated culture pellet 3 9 1 of live bacteria. All honey bees (experimentally infected and controls) were placed for 3 9 2
24h at room temperature in dedicated small cages and fed ad libitum with sugar syrup 3 9 3
(Invertbee from SARL Isnard, France) containing fructose (36%), dextrose (30%), 3 9 4 saccharose (31%), maltose (1.5%) and other sugars (1.5%). Hemolymph was collected 3 9 5
from the dorsal side of the abdomen, using pulled glass capillaries (Sutter Instrument 3 9 6
Corp, Novato, California). The collected hemolymph was immediately transferred into a 3 9 7
chilled LoBind Protein microtube (Eppendorf, Germany) pre-coated with 3 9 8
Phenylthiourea and Phenylmethylsulfonyl fluoride (both from Sigma Aldrich, France) 3 9 9
to prevent melanization and proteolysis, respectively. The hemolymph samples were 4 0 0 stored at -20°C until use. 4 0 1 adjustments. Briefly, the hemolymph samples were 10-fold diluted in acidified water 4 0 7 (0.1% trifluoroacetic acid, Sigma Aldrich, France) and 0.5µ L of a given sample was 4 0 8 mixed with 0.5µ L of 4-HCCA (Sigma Aldrich, France) on a MALDI MTP 384 polished 4 0 9
Molecular mass fingerprints by MALDI MS
ground steel plate (Bruker Daltonik). Following co-crystallization of the hemolymph 4 1 0 spots with the matrix droplet, MALDI MS spectra were recorded in a linear positive 4 1 1 mode and in an automatic data acquisition using FlexControl 4.0 software (Bruker 4 1 2
Daltonik). The follo wing instrument settings were used: 1.5kV of electric potential 4 1 3 difference, dynamic range of detection of 600 to 18,000 Da, 69% of laser power, a 4 1 4
global attenuator offset of 46% with 200Hz laser frequency, and 2,000 accumulated 4 1 5 laser shots per hemolymph spectrum with a raster of random walk set to 50. The linear 4 1 6
detector gain was setup at 1.82kV with a suppression mass gate up to m/z 600 to 4 1 7 prevent detector saturation by clusters of the 4-HCCA matrix. The pseudo-molecular 4 1 8
ions desorbed from the hemolymph were accelerated under 1.5kV. An external 4 1 9
calibration of the mass spectrometer was performed using a standard mixture of 4 2 0 peptides and proteins (Peptide Standard Calibration II and Protein Standard Calibration 4 2 1 I, Bruker Daltonik) covering the dynamic range of analysis. 4 2 2 Data post-processing and statistical analyses 4 2 3
The MALDI-MS datasets were imported into the ClinProTools™ 2.2 Software (Bruker 4 2 4
Daltonik) for post-processing and statistical analyses. All of the recorded spectra were 4 2 5
processed with a baseline subtraction and spectral smoothing followed by an internal 4 2 6
recalibration step with exclusion of null and/or "non-recalibratable" spectra. The total 4 2 7
averaged spectra were calculated based on a signal over noise ratio equal to 5 for peak-4 2 8
picking and area calculations. The irrelevant spectra that did not pass the required 4 2 9 signal intensity and resolution were excluded from any integration into the MALDI-MS 4 3 0
computational model designed to match the biological models of honey bee infections. 4 3 1
A post-processing step involving spectral normalization of all calculated peak area was 4 3 2
performed with ClinProTools™ software prior to statistical analysis (95% confidence 4 3 3
interval, standard deviation and Principal Component Analysis-PCA). 4 3 4
Hierarchical Clustering, heat maps and ROC curves 4 3 5
The total number of spectra used to design the computational models were normalized 4 3 6
and subjected to PCA and unsupervised hierarchical clustering analysis to measure 4 3 7
distances between spectra. This analysis was used to determine Euclidean distances 4 3 8
(based on PCA results with a reduced dimension limited to 70% and 95% of the total 4 3 9
explained variance). (optimal spectral separation combined with the determination of a fixed number of 4 5 5
peaks within the training set) was performed using the Genetic Algorithm (GA) with the 4 5 6
ClinProTools™ software. The GA parameters were as follo w: a maximum of 10 peaks 4 5 7
harboring the greatest weight was selected and included in the model. A number of 50 4 5 8
generations (iterative algorithm searching) was chosen to achieve this maximum of 4 5 9
peaks. The k-nearest neighbor parameter, which is a key parameter of artificial 4 6 0
intelligence used in supervised machine learning, was set at 3. 4 6 1 4 6 2
External validation of the barcode model and classification of unknown spectra 4 6 3
In order to assess the capability of the GA classifier to recognize the infected bees from the control 4 6 4
group, a new set of hemolymph MS spectra, never processed in the classifier model, was used to 4 6 5
perform an external validation. This experimental set of honey bees included the three biological 4 6 6 models; 26 controls, 37 infected honey bees with P. carotovorum subsp. carotovorum 15 and 10 with 4 6 7 M. luteus. By submitting those hemolymph spectra to the classifier resulted in counting the correctly 4 6 8
classified spectra, and also the mismatched and the invalid ones. In order to assess the performance of 4 6 9
our classifier model, accuracy, sensitivity, specificity, informedness, specific-positive and negative 4 7 0 likelihood ratios, false discovery rate (q-value) and false positive rate (p-value) were calculated. The 4 7 1 accuracy, which informs on how efficient the model is, was calculated according to Wang et al. (53) . 4 7 2
Sensitivity scores real positive cases that are correctly predicted positive by the model and the 4 7 3 specificity scores the opposite i.e. the real negative cases that are correctly predicted negative. 4 7 4
Informedness scores the probability that a prediction (e.g. result of a machine-learning model to 4 7 5 classify one condition against the others) is informed regarding to the tested condition versus odds. 4 7 6
Informedness helps to make diagnosis decision. Sensitivity, specificity and informedness were 4 7 7 determined as previously described (54). The specific-positive and -negative likelihood ratios the test lacks diagnostic value and if the ratio is >1, then the test increases the probability to 4 8 5 match correctly with the condition. Regarding -LR, the closer to zero the value is, the more informative the test is (55). We would like to thank Dr. Bruno Lemaitre from the Ecole Polytechnique Fédérale de Lausanne -4 9 0
(EPFL, Switzerland) and the Institut Pasteur de Paris for their generous gifts (Micrococcus luteus 4 9 1 strain and Serratia entomophila respectively). We are also thankful to Paul-Arthur Sol and Erwan 4 9 2
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FEAGA ( 
